DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
Lunasin Regimen
( DrugBank:
Lunasin
/ KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
2
筋萎縮性側索硬化症
1
2. 筋萎縮性側索硬化症
臨床試験数
:
645
/
薬物数
:
589
- (
DrugBank
:
163
) /
標的遺伝子数
:
150
-
標的パスウェイ数
:
225
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT02709330
(
ClinicalTrials.gov
)
April 2016
20160400
5/3/2016
20160305
ALS Reversals -
Lunasin
Regimen
An Open-label, Single-center, 12-month Trial of a
Lunasin
Regimen
for Patients With Amyotrophic Lateral Sclerosis (ALS)
An Open-label, Single-center, 12-month Trial of a
Lunasin
Regimen
for Patients With Amyotrophic Later ...
ALS (Amyotrophic Lateral Sclerosis)
Drug:
Lunasin
Regimen
;Other: Historical control
Richard Bedlack, M.D., Ph.D.
NULL
Completed
18 Years
N/A
All
60
Phase 2
United States